Liu, J.; Pan, S.; Dong, L.; Wu, G.; Wang, J.; Wang, Y.; Qian, H.; Dong, B.; Pan, J.; Zhu, Y.;
et al. The Diagnostic Value of PI-RADS v2.1 in Patients with a History of Transurethral Resection of the Prostate (TURP). Curr. Oncol. 2022, 29, 6373-6382.
https://doi.org/10.3390/curroncol29090502
AMA Style
Liu J, Pan S, Dong L, Wu G, Wang J, Wang Y, Qian H, Dong B, Pan J, Zhu Y,
et al. The Diagnostic Value of PI-RADS v2.1 in Patients with a History of Transurethral Resection of the Prostate (TURP). Current Oncology. 2022; 29(9):6373-6382.
https://doi.org/10.3390/curroncol29090502
Chicago/Turabian Style
Liu, Jiazhou, Shihang Pan, Liang Dong, Guangyu Wu, Jiayi Wang, Yan Wang, Hongyang Qian, Baijun Dong, Jiahua Pan, Yinjie Zhu,
and et al. 2022. "The Diagnostic Value of PI-RADS v2.1 in Patients with a History of Transurethral Resection of the Prostate (TURP)" Current Oncology 29, no. 9: 6373-6382.
https://doi.org/10.3390/curroncol29090502
APA Style
Liu, J., Pan, S., Dong, L., Wu, G., Wang, J., Wang, Y., Qian, H., Dong, B., Pan, J., Zhu, Y., & Xue, W.
(2022). The Diagnostic Value of PI-RADS v2.1 in Patients with a History of Transurethral Resection of the Prostate (TURP). Current Oncology, 29(9), 6373-6382.
https://doi.org/10.3390/curroncol29090502